Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makda S Gebre

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Antiviral Research|August 16, 2016
Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 miceAlmut H Vollmer, Makda S Gebre, Dale L Barnard
Cell|March 19, 2021
Novel approaches for vaccine developmentMakda S Gebre, Luis A Brito, Lisa H Tostanoski, et al.
Biorxiv : the Preprint Server for Biology|November 9, 2021
mRNA Vaccines Induce Rapid Antibody Responses in MiceMakda S Gebre, Susanne Rauch, Nicole Roth, et al.
NPJ Vaccines|August 1, 2022
mRNA vaccines induce rapid antibody responses in miceMakda S Gebre, Susanne Rauch, Nicole Roth, et al.
Journal of Virology|March 17, 2021
Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization AssaysJingyou Yu, Zhenfeng Li, Xuan He, et al.
Plos Pathogens|December 17, 2019
Alpha-defensin 5 differentially modulates adenovirus vaccine vectors from different serotypes in vivoLawrence J Tartaglia, Alexander Badamchi-Zadeh, Peter Abbink, et al.
Abdominal Radiology (New York)|September 17, 2020
Feasibility and safety of ultrasound-guided minimally invasive autopsy in COVID-19 patientsOlga R Brook, Kimberly G Piper, Noe B Mercado, et al.
NPJ Vaccines|February 24, 2022
Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of miceShant H Mahrokhian, Lisa H Tostanoski, Catherine Jacob-Dolan, et al.
Advanced Healthcare Materials|October 4, 2021
A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 AntigensFernanda Langellotto, Maxence O Dellacherie, Chyenne Yeager, et al.
Science Translational Medicine|July 20, 2022
Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunityBrittany L Hartwell, Mariane B Melo, Peng Xiao, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Antiviral Research|August 16, 2016
Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 miceAlmut H Vollmer, Makda S Gebre, Dale L Barnard
Cell|March 19, 2021
Novel approaches for vaccine developmentMakda S Gebre, Luis A Brito, Lisa H Tostanoski, et al.
Biorxiv : the Preprint Server for Biology|November 9, 2021
mRNA Vaccines Induce Rapid Antibody Responses in MiceMakda S Gebre, Susanne Rauch, Nicole Roth, et al.
NPJ Vaccines|August 1, 2022
mRNA vaccines induce rapid antibody responses in miceMakda S Gebre, Susanne Rauch, Nicole Roth, et al.
Journal of Virology|March 17, 2021
Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization AssaysJingyou Yu, Zhenfeng Li, Xuan He, et al.
Plos Pathogens|December 17, 2019
Alpha-defensin 5 differentially modulates adenovirus vaccine vectors from different serotypes in vivoLawrence J Tartaglia, Alexander Badamchi-Zadeh, Peter Abbink, et al.
Abdominal Radiology (New York)|September 17, 2020
Feasibility and safety of ultrasound-guided minimally invasive autopsy in COVID-19 patientsOlga R Brook, Kimberly G Piper, Noe B Mercado, et al.
NPJ Vaccines|February 24, 2022
Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of miceShant H Mahrokhian, Lisa H Tostanoski, Catherine Jacob-Dolan, et al.
Advanced Healthcare Materials|October 4, 2021
A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 AntigensFernanda Langellotto, Maxence O Dellacherie, Chyenne Yeager, et al.
Science Translational Medicine|July 20, 2022
Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunityBrittany L Hartwell, Mariane B Melo, Peng Xiao, et al.
Pageof 2